DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

DaVita Inc.

The pharma company’s share price soared on news of a cancer drug breakthrough. 


Moderna Stock (MRNA) Was the Best Performer in August

Endovia Health Sciences Inc ( ($EDVA) ) just unveiled an update. On August 25, 2026, Endovia Health Sciences announced that the U.S. Food and Drug ...

Endovia launches FDA-backed CannEpil veterinary pain program

In a report released on August 11, David S Macdonald from Truist Financial maintained a Hold rating on DaVita, with a price target of $215.00. The ...

Truist Financial Remains a Hold on DaVita (DVA)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hims & Hers Health (HIMS), Lifestance Health Group (LFST) and DaV...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DVA	$183.06	+0.77%	103.72K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DVA	$183.06	+0.8%	103.72K
3
4
5
6

DVA

Get DaVita Inc. Data in Excel

Get DaVita Inc. Data in Excel